Terms: = Head and neck cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
961 results:
1. Enhanced ctla-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.
Shin DS; Basak S; Veena MS; Comin-Anduix B; Bhattacharya A; Dong TS; Ko A; Han P; Jacobs J; Moatamed NA; Avila L; Pellegrini M; Wang M; Srivatsan ES
Cancer Med; 2024 May; 13(9):e7212. PubMed ID: 38686626
[TBL] [Abstract] [Full Text] [Related]
2. Verification of the expression trend and interaction prediction of innate immune cells and immune-checkpoint molecules in the process of oral mucosal carcinogenesis.
Li K; Shi L; Liu L; Wang J; Nie M; Liu X
Hua Xi Kou Qiang Yi Xue Za Zhi; 2024 Apr; 42(2):192-206. PubMed ID: 38597079
[TBL] [Abstract] [Full Text] [Related]
3. The influence of postoperative outcomes on survival after esophageal cancer surgery: validation of a consensus-based updated textbook outcome parameter.
D'Souza J; Cinelli DP; McCombie A; Roberts R
J Gastrointest Surg; 2024 Apr; 28(4):343-350. PubMed ID: 38583882
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.
Ji G; Yang Q; Wang S; Yan X; Ou Q; Gong L; Zhao J; Zhou Y; Tian F; Lei J; Mu X; Wang J; Wang T; Wang X; Sun J; Zhang J; Jia C; Jiang T; Zhao MG; Lu Q
Genome Med; 2024 Apr; 16(1):49. PubMed ID: 38566201
[TBL] [Abstract] [Full Text] [Related]
5. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
Lu D; Mihoayi M; Ablikim Y; Arikin A
Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
[TBL] [Abstract] [Full Text] [Related]
6. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.
Wang Y; Peng L; Wang F
Cancer Biol Ther; 2024 Dec; 25(1):2333590. PubMed ID: 38532632
[TBL] [Abstract] [Full Text] [Related]
7. Long-term outcomes of robot-assisted versus minimally invasive esophagectomy in patients with thoracic esophageal cancer: a propensity score-matched study.
Sakurai T; Hoshino A; Miyoshi K; Yamada E; Enomoto M; Mazaki J; Kuwabara H; Iwasaki K; Ota Y; Tachibana S; Hayashi Y; Ishizaki T; Nagakawa Y
World J Surg Oncol; 2024 Mar; 22(1):80. PubMed ID: 38504312
[TBL] [Abstract] [Full Text] [Related]
8. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia.
Aikins ME; Sun X; Dobson H; Zhou X; Xu Y; Lei YL; Moon JJ
J Control Release; 2024 Apr; 368():768-779. PubMed ID: 38492861
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Qi L; Tang Z
Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
[TBL] [Abstract] [Full Text] [Related]
10. Dual checkpoint T(h1)eamwork makes the anti-cancer dream work.
Dietl A; Ralser A; Pelka K
Immunity; 2024 Mar; 57(3):406-408. PubMed ID: 38479356
[TBL] [Abstract] [Full Text] [Related]
11. The Use of Immune Regulation in Treating head and neck Squamous Cell Carcinoma (HNSCC).
Wang CW; Biswas PK; Islam A; Chen MK; Chueh PJ
Cells; 2024 Feb; 13(5):. PubMed ID: 38474377
[TBL] [Abstract] [Full Text] [Related]
12. CD4
Franken A; Bila M; Mechels A; Kint S; Van Dessel J; Pomella V; Vanuytven S; Philips G; Bricard O; Xiong J; Boeckx B; Hatse S; Van Brussel T; Schepers R; Van Aerde C; Geurs S; Vandecaveye V; Hauben E; Vander Poorten V; Verbandt S; Vandereyken K; Qian J; Tejpar S; Voet T; Clement PM; Lambrechts D
Immunity; 2024 Mar; 57(3):541-558.e7. PubMed ID: 38442708
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data.
Lippenszky L; Mittendorf KF; Kiss Z; LeNoue-Newton ML; Napan-Molina P; Rahman P; Ye C; Laczi B; Csernai E; Jain NM; Holt ME; Maxwell CN; Ball M; Ma Y; Mitchell MB; Johnson DB; Smith DS; Park BH; Micheel CM; Fabbri D; Wolber J; Osterman TJ
JCO Clin Cancer Inform; 2024 Feb; 8():e2300207. PubMed ID: 38427922
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
Chen QY; Guo SS; Luo Y; Qu S; Wu DH; Chen XZ; Chen DP; Qin XT; Lin Q; Jin F; Lin SJ; Yao ZF; Liu W; Maxwell Wang Z; Li BY; Xia M; Xu RH; Tang LQ; Mai HQ
Oral Oncol; 2024 Apr; 151():106723. PubMed ID: 38387261
[TBL] [Abstract] [Full Text] [Related]
15. Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 in head and neck cancer.
Basak NP; Jaganathan K; Das B; Muthusamy O; M R; Malhotra R; Samal A; Nath M; Ms G; Shankar AP; Bv P; Pillai V; Bv M; C J; K V; K GS; Govindan S; V S; Juby ; R K; Bhowal C; Kumar U; K G; Malhotra M; Sankaran S
Nat Commun; 2024 Feb; 15(1):1585. PubMed ID: 38383563
[TBL] [Abstract] [Full Text] [Related]
16. INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Hilton JF; Ott PA; Hansen AR; Li Z; Mathew M; Messina CH; Dave V; Ji X; Karpinich NO; Hirschfeld S; Ballas M; Zandberg DP
Cancer Immunol Immunother; 2024 Feb; 73(3):44. PubMed ID: 38349570
[TBL] [Abstract] [Full Text] [Related]
17. Different patient versus provider perspectives on living with Cushing's disease.
Halstrom A; Lin IH; Lin A; Cohen M; Tabar V; Geer EB
Pituitary; 2024 Apr; 27(2):141-150. PubMed ID: 38315244
[TBL] [Abstract] [Full Text] [Related]
18. Immunotherapy for non-small cell lung cancer.
Kagamu H
Respir Investig; 2024 Mar; 62(2):307-312. PubMed ID: 38310751
[TBL] [Abstract] [Full Text] [Related]
19. Deep learning for head and neck semi-supervised semantic segmentation.
Luan S; Ding Y; Shao J; Zou B; Yu X; Qin N; Zhu B; Wei W; Xue X
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38306968
[No Abstract] [Full Text] [Related]
20. Clear cell oral squamous cell carcinoma as a diagnostic conundrum: report of 2 rare cases.
Sharma K; Chauhan A; Sharma P; Wadhwan V; Tyagi S; Sharma R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; 137(5):e83-e90. PubMed ID: 38281881
[TBL] [Abstract] [Full Text] [Related]
[Next]
